Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.

A. A. Forastiere, D. R. Budman, F. Richards, J. Aisner, V. Weinberg, W. C. Wood

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1137-1138
Number of pages2
JournalCancer Treatment Reports
Volume67
Issue number12
StatePublished - Dec 1983
Externally publishedYes

Fingerprint

Naphthacenes
Aclarubicin
Drug Evaluation
Gastrointestinal Diseases
Leukopenia
Thrombocytopenia
Leukemia
Breast Neoplasms
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Forastiere, A. A., Budman, D. R., Richards, F., Aisner, J., Weinberg, V., & Wood, W. C. (1983). Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study. Cancer Treatment Reports, 67(12), 1137-1138.

Phase II trial of aclarubicin in advanced breast cancer : a cancer and leukemia group B study. / Forastiere, A. A.; Budman, D. R.; Richards, F.; Aisner, J.; Weinberg, V.; Wood, W. C.

In: Cancer Treatment Reports, Vol. 67, No. 12, 12.1983, p. 1137-1138.

Research output: Contribution to journalArticle

Forastiere, AA, Budman, DR, Richards, F, Aisner, J, Weinberg, V & Wood, WC 1983, 'Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.', Cancer Treatment Reports, vol. 67, no. 12, pp. 1137-1138.
Forastiere, A. A. ; Budman, D. R. ; Richards, F. ; Aisner, J. ; Weinberg, V. ; Wood, W. C. / Phase II trial of aclarubicin in advanced breast cancer : a cancer and leukemia group B study. In: Cancer Treatment Reports. 1983 ; Vol. 67, No. 12. pp. 1137-1138.
@article{b85e651461da4e88a31765361102b0c8,
title = "Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.",
author = "Forastiere, {A. A.} and Budman, {D. R.} and F. Richards and J. Aisner and V. Weinberg and Wood, {W. C.}",
year = "1983",
month = "12",
language = "English (US)",
volume = "67",
pages = "1137--1138",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Phase II trial of aclarubicin in advanced breast cancer

T2 - a cancer and leukemia group B study.

AU - Forastiere, A. A.

AU - Budman, D. R.

AU - Richards, F.

AU - Aisner, J.

AU - Weinberg, V.

AU - Wood, W. C.

PY - 1983/12

Y1 - 1983/12

UR - http://www.scopus.com/inward/record.url?scp=0020984837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020984837&partnerID=8YFLogxK

M3 - Article

C2 - 6580949

VL - 67

SP - 1137

EP - 1138

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 12

ER -